Publicaciones

Consulta nuestras publicaciones

PUBLICACIONES

Desde el año 2007 GENVIP ha publicado más de 430 publicaciones

Mostrando 0 de
0 publicaciones
highlight
Resetear todo

Año

Borrar

Journal

Borrar
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
FEBRILE CHILDREN WITH COMORBIDITIES AT THE EMERGENCY DEPARTMENT - A MULTICENTRE OBSERVATIONAL STUDY
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, van der Velden FJS, Vermont C, Zavadska D, Zenz W, Zachariasse JM, Moll HA
Journal:
Eur J Pediatr
Publicación independiente
Factor de impacto:
3.860
Q1
RSV PREVENTION IN ALL INFANTS: WHICH IS THE MOST PREFERABLE STRATEGY?
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S
Journal:
Front Immunol
Publicación independiente
Factor de impacto:
8.876
Q1
RISK ANALYSIS BY AGE ON THE BURDEN OF MENINGOCOCCAL DISEASE IN SPAIN
Rivero-Calle I, Raguindin PF, Pardo-Seco J, Martinon-Torres F
Journal:
Vaccines
Publicación independiente
Factor de impacto:
4.961
Q2
MENINGOCOCCAL B VACCINE EFFECTIVENESS
Banzhoff A, Martinón-Torres F
Journal:
J Pediatr
Publicación independiente
Factor de impacto:
6.314
Q1
GLOBAL, REGIONAL, AND NATIONAL DISEASE BURDEN ESTIMATES OF ACUTE LOWER RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN YOUNGER THAN 5 YEARS IN 2019: A SYSTEMATIC ANALYSIS
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markić J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ; Respiratory Virus Global Epidemiology Network, Nair H; RESCEU investigators (Martinón-Torres F)
Journal:
Lancet
Publicación independiente
Factor de impacto:
202.710
Q1
Year:
2022
Doi:
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Factor de impacto:
6.333
Q1
A TOOL FOR EARLY ESTIMATION OF INFLUENZA VACCINATION COVERAGE IN SPANISH GENERAL POPULATION AND HEALTHCARE WORKERS IN THE 2018-19 SEASON: THE GRIPÓMETRO
Díez-Domingo J, Redondo Margüello E, Ortiz de Lejarazu Leonardo R, Gil de Miguel Á, Guillén Ortega JM, Rincón Mora J, Martinón-Torres F
Journal:
BMC Public Health
Publicación independiente
Factor de impacto:
4.135
Q2
WHOOPING COUGH: THE VISIBLE ENEMY
González-Barcala FJ, Villar-Álvarez F, Martinón-Torres F
Journal:
Arch Bronconeumol
Publicación independiente
Factor de impacto:
6.333
Q1
ROLE AND DIAGNOSTIC PERFORMANCE OF HOST EPIGENOME IN RESPIRATORY MORBIDITY AFTER RSV INFECTION: THE EPIRESVI STUDY.
Pischedda S, Rivero-Calle I, Gómez-Carballa A, Cebey-López M, Barral-Arca R, Gómez-Rial J, Pardo-Seco J, Curras-Tuala MJ, Viz-Lasheras S, Bello X, Crujeiras AB, Diaz-Lagares A, González-López MT, Martinón-Torres F, Salas A; GENDRES consortium
Journal:
Front Immunol
Publicación independiente
Factor de impacto:
8.786
Q1
EVALUATION OF BNT162B2 VACCINE EFFECTIVENESS IN GALICIA, NORTHWEST SPAIN
Pardo-Seco J, Mallah N, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F
Journal:
Int J Environ Res Public Health
Publicación independiente
Factor de impacto:
3.390
Q2
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Factor de impacto:
4.872
Q2
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Journal:
J Clin Epidemiol
Publicación independiente
Factor de impacto:
6.437
Q1
Year:
2022
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Factor de impacto:
5.226
Q1
Year:
2022
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Journal:
J Neurodev Disord
Publicación independiente
Factor de impacto:
4.025
Q2
Year:
2022
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Factor de impacto:
5.226
Q1
Year:
2022
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Journal:
Pediatr Infect Dis J
Publicación independiente
Factor de impacto:
2.129
Q4
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Journal:
An Pediatr (Engl Ed)
Publicación independiente
Factor de impacto:
1.500
Q4
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Factor de impacto:
5.022
Q1
Year:
2022
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Journal:
Expert Rev Vaccines
Publicación independiente
Factor de impacto:
5.217
Q2
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Journal:
Environ Res
Publicación independiente
Factor de impacto:
6.498
Q1
CHARACTERISTICS AND MANAGEMENT OF ADOLESCENTS ATTENDING THE ED WITH FEVER: A PROSPECTIVE MULTICENTRE STUDY
Borensztajn D, Hagedoorn NN, Carrol E, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon Torres F, Nijman R, Pokorn M, Rivero-Calle I, Tsolia M, Vermont C, Zavadska D, Zenz W, Zachariasse J, Moll HA; PERFORM Consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union.
Journal:
BMJ Open
Publicación independiente
Factor de impacto:
2.692
Q2
EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS
Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V
Journal:
Pathog Glob Health
Publicación independiente
Factor de impacto:
2.894
Q2
IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)
Cook A, Sharland M, Yau Y; PediBSI Group*, Bielicki J. (Martinón-Torres F)
Journal:
Expert Rev Anti Infect Ther.
Publicación independiente
Factor de impacto:
5.091
Q1
Year:
2022
Doi:
No se han encontrado resultados.
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Doi:
Arch Bronconeumol
Factor de impacto:
Q2
Doi:
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Doi:
J Clin Epidemiol
Factor de impacto:
Q1
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Doi:
J Neurodev Disord
Factor de impacto:
Q2
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Doi:
Pediatr Infect Dis J
Factor de impacto:
Q4
Doi:
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Doi:
An Pediatr (Engl Ed)
Factor de impacto:
Q4
Doi:
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Doi:
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Doi:
Environ Res
Factor de impacto:
Q1
Doi:
SIMULTANEOUS VIRAL WHOLE-GENOME SEQUENCING AND DIFFERENTIAL EXPRESSION PROFILING IN RESPIRATORY SYNCYTIAL VIRUS INFECTION OF INFANTS
Gu-Lung Lin, Tanya Golubchik, Simon Drysdale, Daniel O’Connor, Kimberley Jefferies, Anthony Brown, Mariateresa de Cesare, David Bonsall, M. Azim Ansari, Jeroen Aerssens, Louis Bont, Peter Openshaw, Federico Martinón-Torres, Rory Bowden, and Andrew J. Pollard; the RESCEU Investigators
The Journal of Infectious Diseases
Factor de impacto:
Q1
Doi:
IDENTIFICATION OF NOVEL RISK LOCI AND CAUSAL INSIGHTS FOR SPORADIC CREUTZFELDT-JAKOB DISEASE: A GENOME-WIDE ASSOCIATION STUDY
Emma Jones, Holger Hummerich, Emmanuelle Viré, James Uphill, Athanasios Dimitriadis, Helen Speedy, Tracy Campbell, Penny Norsworthy, Liam Quinn, Jerome Whitfield, Jacqueline Linehan, Zane Jaunmuktane, Sebastian Brandner, Parmjit Jat, Akin Nihat, Tze How Mok, Parvin Ahmed, Steven Collins, Christiane Stehmann, Shannon Sarros, Gabor G Kovacs, Michael D Geschwind, Aili Golubjatnikov, Karl Frontzek, Herbert Budka, Adriano Aguzzi, Hata Karamujić-Čomić, Sven J van der Lee, Carla A Ibrahim-Verbaas, Cornelia M Van Duijn, Beata Sikorska, Ewa Golanska, Pawel Liberski, Miguel Calero, Olga Calero, Pascual Sanchez-Juan, Antonio Salas, Federico Martinón-Torres, Elodie Bouaziz-Amar, Stephane Haik, Jean-Louis Laplanche, Jean-Phillipe Brandel, Phillipe Amouyel, Jean-Charles Lambert, Piero Parchi, Anna Bartoletti-Stella, Sabina Capellari, Anna Poleggi, Anna Ladogana, Maurizio Pocchiari, Serena Aneli, Giuseppe Matullo, Richard Knight, Saima Zafar, Inga Zerr, Stephanie Booth, Michael B Coulthart, Gerard H Jansen, Katie Glisic, Janis Blevins, Pierluigi Gambetti, Jiri Safar, Brian Appleby, John Collinge, Simon Mead
Factor de impacto:
Doi:
SEROPREVALENCE OF SARS-COV-2 AMONG PEDIATRIC HEALTHCARE WORKERS IN SPAIN
Ana Dacosta-Urbieta, Irene Rivero-Calle, Jacobo Pardo-Seco, Lorenzo Redondo-Collazo, Antonio Salas, Jose Gómez-Rial and Federico Martinón-Torres
Factor de impacto:
Doi:
ROLE OF MONOCYTES/MACROPHAGES IN COVID-19 PATHOGENESIS: IMPLICATIONS FOR THERAPY.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F.
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU) BIRTH COHORT STUDY: DEFINING THE BURDEN OF INFANT RESPIRATORY SYNCYTIAL VIRUS DISEASE IN EUROPE
Joanne G Wildenbeest, Roy P Zuurbier, Koos Korten, Marlies A van Houten, Marie N Billard, Nicole Derksen-Lazet, Matthew D Snape, Simon B Drysdale, Hannah Robinson, Andrew J Pollard, Terho Heikkinen, Steve Cunningham, Amanda Leach, Federico Martinón-Torres, Carmen Rodríguez-Tenreiro Sánchez, Alberto Gómez-Carballa, Louis J Bont, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
PRESUMED RISK FACTORS AND BIOMARKERS FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS DISEASE AND RELATED SEQUELAE: PROTOCOL FOR AN OBSERVATIONAL MULTICENTER, CASE-CONTROL STUDY FROM THE RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU)
Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, Elizabeth Ann Clutterbuck, Luke Blackwell, Joseph McGinley, Gu-Lung Lin, Ushma Galal, Harish Nair, Jeroen Aerssens, Deniz Öner, Annefleur Langedijk, Louis Bont, Joanne G Wildenbeest, Federico Martinon-Torres, Carmen Rodríguez-Tenreiro Sánchez, Simon Nadel, Peter Openshaw, Ryan Thwaites, Myra Widjojoatmodjo, Linong Zhang, Thi Lien-Anh Nguyen, Carlo Giaquinto, Giuseppe Giordano, Eugenio Baraldi, Andrew J Pollard, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
BIOMARKERS FOR DISEASE SEVERITY IN CHILDREN INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS: A SYSTEMATIC LITERATURE REVIEW
Öner D, Drysdale SB, McPherson C, Lin GL, Janet S, Broad J, Pollard AJ, Aerssens J; RESCEU Investigators (F Martinón-Torres)
Factor de impacto:
Doi:
BIOMARKERS FOR THE DISCRIMINATION OF ACUTE KAWASAKI DISEASE FROM INFECTIONS IN CHILDHOOD
Judith Zandstra, Annemarie van de Geer, Michael W T Tanck, Diana van Stijn-Bringas, Dimitriades, Cathelijn E M Aarts, Sanne M Dietz, Robin van Bruggen, Nina A Schweintzger, Werner Zenz, Marieke Emonts, Dace Zavadska, Marko Pokorn, Effua Usuf, Henriette A Moll, Luregn J Schlapbach, Enitan D Carrol, Stephane Paulus, Maria Tsolia, Colin Fink, Shunmay Yeung, Chisato Shimizu, Adriana Tremoulet, Rachel Galassini, Victoria J Wright, Federico Martinón-Torres, Jethro Herberg, Jane Burns, Michael Levin, Taco W Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
Factor de impacto:
Doi:
SINGLE-DOSE NIRSEVIMAB FOR PREVENTION OF RSV IN PRETERM INFANTS
M. Pamela Griffin, Yuan Yuan, Therese Takas, Joseph B. Domachowske, Shabir A. Madhi, Paolo Manzoni, Eric A.F. Simões, Mark T. Esser, Anis A. Khan, Filip Dubovsky, Tonya Villafana and John P. DeVincenzo for the Nirsevimab Study Group*(Federico Martinón Torres)
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS VACCINATION DURING PREGNANCY AND EFFECTS IN INFANTS
S.A. Madhi, F.P. Polack, P.A. Piedra, F.M. Munoz, A.A. Trenholme, E.A.F. Simões, G.K. Swamy, S. Agrawal, K. Ahmed, A. August, A.H. Baqui, A. Calvert, J. Chen, I. Cho, M.F. Cotton, C.L. Cutland, J.A. Englund, A. Fix, B. Gonik, L. Hammitt, P.T. Heath, J.N. de Jesus, C.E. Jones, A. Khalil, D.W. Kimberlin, R. Libster, C.J. Llapur, M. Lucero, G. Pérez Marc, H.S. Marshall, M.S. Masenya,F. Martinón‐Torres, J.K. Meece, T.M. Nolan, A. Osman, K.P. Perrett, J.S. Plested, P.C. Richmond, M.D. Snape, J.H. Shakib, V. Shinde, T. Stoney, D.N. Thomas, A.T. Tita, M.W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H.J. Zar, G.M. Glenn, and L.F. Fries, for the Prepare Study Group*
Factor de impacto:
Doi: